Feature | April 21, 2011| Dave Fornell

Robots Arrive to Open Arms in the Cath Lab – the Future is Almost Here

The start-up company Corindus for several years has been developing a robotic-assist system for use in the cardiac cath lab. It not only navigates devices to target lesions, but also can be used to precisely guide, manipulate and deploy devices during interventional procedures. The system allows the operator to sit in a lead-shielded booth in the cath lab to perform procedures away from the table and outside of the radiation field. Operators work while sitting down, without lead aprons and with more precision than allowed with hand manipulation.

At Transcatheter Cardiovascular Therapeutics (TCT) 2010, there was a lot of interest by attendees in the system. Diagnostic and Interventional Cardiology Editorial Advisory Board members who attended TCT ranked it among the top technologies to pay attention to. They said it offers a promise of a safer working environment for physicians, better precision, and the elimination of back pain and fatigue because the operator no longer needs to wear heavy lead protective aprons.

This system did not escape notice by the large angiography system/cath lab install companies. In fact, Philips Healthcare jumped at the opportunity to work with Corindus and announced April 21, 2011 an agreement to add CorPath to Philips’ interventional cardiology solutions. As part of the agreement, Philips has also acquired a minority stake in Corindus.

This partnership and financial stake in Corindus shows a big vote of confidence in the technology, since CorPath just began its U.S. Food and Drug Administration pivotal trial in March and is not yet approved for clinical use in the United States.

Philips, GE, Toshiba and Siemens all offer top-of-the-line angiography systems and entire cath lab installation packages. Each makes strides each year to improve their products and stay ahead of the competition. I believe this step to partner with and take a financial stake in Corindus will be a major step forward for Philips. In addition, Philips purchased other technologies in the past two years to aid cath lab navigation imaging and advance fusion imaging techniques.

The future seems bright for robotic systems in the cath lab. The stage has already been set on the surgical side of the cardiovascular department, where the da Vinci robotic surgical assistance system has made major in-roads for its ability for better precision, decreasing surgeon fatigue and enabling greater patient throughput.

I would be interested in hearing your views on the use of robotic systems in the cath lab. You can e-mail me at [email protected]

Related Content

Infinix 4D CT

Toshiba's Infinix 4D CT, which combines CT with angiography in the interventional lab.

Feature | Angiography| September 28, 2016 | Tom Watson BS, RCVT, Clinical Analyst, MD Buyline
One of the more significant advancements for interventional X-ray (IXR) in the past few years has been a significantl
Transesophageal Echo, TEE. Interventional echocardiography, interventional echo, Philips, CX50

Transesophageal echo (TEE) has become an essential part of the new transcatheter structrual heart therapies, giving rise to a new sub-speciality of interventional echocardiography.  

Feature | Cath Lab Navigation Aids| September 21, 2016 | Dave Fornell
The rapid growth of transcatheter structural heart procedures and the need for increased use of echocardiography as a
atomic bombs, radiation exposure, long-term health effects, Bertrand Jordan, study
News | Radiation Dose Management| August 19, 2016
The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific...
Corindus Corpath, Acist Medical RXi and CVi, Fairview Southdale Hospital, Minnesota, cath lab
News | Cath Lab| August 17, 2016
Corindus Vascular Robotics Inc. and Acist Medical Systems Inc. are providing Fairview Southdale Hospital, Edina, Minn...
Cath lab radiation dose, dose reduction, cath lab staff radiation dose
Feature | Radiation Dose Management| August 09, 2016 | Dave Fornell
In the past few years, concern has skyrocketed from interventional cardiologists and cath lab staff over radiation do
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
 
Stryker Sustainability Solutions, Angiodynamics Soft Vu Omni Flush Angiographic Catheters, recall
News | Angiographic Catheter| July 25, 2016
Stryker Sustainability Solutions (formerly Ascent Healthcare Solutions) is recalling Angiodynamics Soft Vu Omni Flush...
SJM, OCT, Optical coherence tomography, Bioresorbable stent, BVS

Both IVUS and OCT imaging can be used to visualize bioresorbable stents. This optical coherence tomography (OCT) image shows an Absorb bioresorbable stent. The stent struts are clear, allowing light to pass through, and in some cases magnifying the light that passes through under each strut. Image courtesy of St. Jude Medical.

Feature | Stents Bioresorbable| July 21, 2016 | Alphonse Ambrosia, D.O.
Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of inter
Overlay Init